ERA PerMed 2019 - APP transnational dans le cadre de l'ERA PerMed co-fund

Quantifying systemic immunosuppression to personalize cancer therapy – SERPENTINE

Project coordination

Licia Rivoltini (Fondazione IRCCS Istituto Nazionale dei Tumori)

The author of this summary is the project coordinator, who is responsible for the content of this summary. The ANR declines any responsibility as for its contents.

Partner

Oslo University Hospital (OUH)
Fondazione IRCCS Istituto Nazionale dei Tumori
German Cancer Research Center (DKFZ)
Faculty of Science, Tanta University
ICM INSTITUT REGIONAL DU CANCER DE MONTPELLIER
ASST Papa Giovanni XXIII

Help of the ANR 250,000 euros
Beginning and duration of the scientific project: August 2020 - 36 Months

Useful links

Explorez notre base de projets financés

 

 

ANR makes available its datasets on funded projects, click here to find more.

Sign up for the latest news:
Subscribe to our newsletter